This effect on heart rate is an important safety issue that needs special attention in future trials since obese individuals are at increased cardiovascular risk
BPC-157 5mg BPC-157 (Body Protection Compound-157) is one of the most widely studied peptides in regenerative medicine research
ERR agonism is mechanistically distinct in that it amplifies the transcriptional machinery for oxidative metabolism rather than directly uncoupling mitochondria or stimulating adrenergic pathways
Research-Use Only Properly labeled and handled for licensed research use.
After the study, it was observed that both the peptides appeared to have the potential to restore basic bodily functions in geriatric subjects including improved functions in the cardiovascular, endocrine, immune, and nervous systems, along with normalized metabolic and hemostatic activities
the TauRx hydromethylthionine (HMTM/LMTM) tau-inhibitor derivative that reached the Phase 3 LUCIDITY Alzheimers trial and a July 2024 UK MHRA application